INVO Fertility prices 2.37M shares at $1.69 in private placement

INVO Fertility (IVF) entered into a securities purchase agreement with a single institutional investor to purchase 2,366,864 shares of common stock together with warrants to purchase up to an aggregate 4,733,728 shares of common stock, in a private placement priced at-the-market under Nasdaq rules. The combined effective offering price for each share of common stock and accompanying warrants is $1.69. The warrants will have an exercise price of $1.69 per share, will be exercisable upon shareholder approval and will expire on the five year anniversary from such date of shareholder approval. The gross proceeds to the Company from the Offering are estimated to be approximately $4M before deducting the placement agent’s fees and other estimated Offering expenses. The Offering is expected to close on or about December 3, 2025, subject to the satisfaction of customary closing conditions. Maxim Group is acting as the sole placement agent in connection with the Offering.